Board Changes

RNS Number : 0851O
Microsaic Systems plc
05 February 2021
 

 

5 February 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board changes

Microsaic (AIM: MSYS), the point-of-need mass spectrometry company, is pleased to announce that, further to the fundraise announcements on 19 January 2021 and the passing of the resolutions at the General Meeting held yesterday, Gerard Brandon and Dr Nigel Burton are appointed to the Board of the Company as Non-Executive Chairman and Non-executive Director respectively, with effect from 8.00 a.m. today.

The Finance & Audit and Remuneration Committees will be chaired by Dr. Nigel Burton, and Gerard Brandon will be a member of both committees. Dr. Nigel Burton will assume the responsibilities of Senior Non-Executive Director. These arrangements will be reviewed when an independent Non-executive Director joins the Board.

 

Gerard Brandon is Chief Executive Officer of both DeepVerge plc and Cellulac plc. In 1996 he became founder and CEO of Alltracel Pharmaceuticals plc ("Alltracel"), where he built a team which oversaw numerous patents granted on refined cellulose.  Alltracel was admitted to trading on AIM in 2001. In 2004, he was appointed as a Managing Partner for Farmabrand Private Equity. In March 2020, he was appointed as a Non-executive Chairman to Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020. Gerard is a Fellow of the Ryan Academy of Entrepreneurs in Dublin.

Dr. Nigel Burton spent over 14 years as an investment banker at leading City institutions including UBS Warburg and Deutsche Bank, including as the Managing Director responsible for the energy and utilities industries. Nigel spent 15 years as Chief Financial Officer or Chief Executive Officer of a number of private and public companies. Nigel is currently a Non-executive Director of LSE Main Market listed BlackRock Throgmorton Trust plc, and of the AIM quoted companies Digitalbox plc, eEnergy Group plc and Mobile Streams plc. In February 2020, he was appointed as a Non-executive Director of Modern Water plc, which was subsequently acquired by DeepVerge plc (formerly Integumen plc) in November 2020, following which he became a Non-executive Director of DeepVerge plc.

As anticipated in the Circular published on 19 January 2021, Peter Grant, Non-executive Chairman and Eric Yeatman, Non-executive Director, stepped down from the Board with effect from 8.00 a.m. today.   Eric Yeatman will be retained as a consultant.

Gerard Brandon, Chairman, said:

"Nigel and I are delighted to be joining the Board and look forward to working with, and supporting, management to commercialise the amazing technology built over the last 19 years. Investing in the recent Placing and taking our respective Director fees only in shares, we have full confidence for the future of Microsaic.

The Company would also like to take this opportunity to thank Peter Grant for his contribution as Chairman over the past three years and Professor Eric Yeatman for his contribution as one of the original founders of the Company and a Director since 2001. We are pleased to be retaining Eric as a consultant to the Company given his expert knowledge of the Company's technology and business."

 

  Enquiries:

Microsaic Systems plc

 

 

 

Glenn Tracey, CEO

+44 (0) 1483 751 577

Bevan Metcalf, FD

 

 

N+1 Singer

 

+44 (0) 20 7496 3000

(Nominated Adviser and Joint Broker)
Aubrey Powell / George Tzimas / Tom Salvesen

 

 

Turner Pope Investments (TPI) Limited  (Joint Broker)

+44 (0) 20 3657 0050

Zoe Alexander / Andy Thacker

 

 

 

In accordance with obligations under the AIM Rules Schedule 2(g), Gerard James Brandon, 59, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships



Innovenn UK Ltd

Visible Youth Limited

Deepverge plc (nee Integumen plc)

VY Club Ltd

Pursuit Marine Drive Ltd


Cellulac plc


Cellulac Trading Ltd


Rincloud Ltd


Modern Water plc


Parity Group plc

Integumen Ltd

LifescienceHub UK Limited

AER Sustainable Energy Limited

LifescienceHub Ireland Limited

Integumen Ireland Limited

Stoer Ireland Limited


 


In accordance with obligations under the AIM Rules Schedule 2(g), Dr. Nigel John Burton, 62, holds or has held the following directorships in the previous five years:

Current directorships

Past directorships



Wasdale Head Limited

Management Resource Solutions plc

Wasdale Head Inn Limited

Nu-Oil and Gas plc

SenseToys Limited

Remote Monitored Systems plc

ASD Visual Aids Limited

GyroMetric Systems Limited

Digitalbox plc

Strat Aero International Limited

Tau Capital plc

UKAerovision Limited

Energy Group plc

Corcel plc

Mobile Streams plc


Streams Data Limited


Mobile Streams Inc


Modern Water plc


eEnergy Holdings Limited


DeepVerge plc


Blackrock Throgmorton Trust plc


 


 

Dr Burton was a director of Pease Limited within the 12 months prior to the company appointing a liquidator in June 1998. The company was subsequently liquidated in 2002.

 

There is no further information to be disclosed pursuant to Schedule 2(g) of the AIM Rules for Companies.

Dr. Burton currently holds 500,000 ordinary shares in Microsaic Systems plc.  A separate announcement is today being made confirming the interests of Mr. Brandon and Dr. Burton following completion of the fundraising for the Company.

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company which develops point-of-need mass spectrometers (MS) designed to improve the efficiency of chemical and biological workflows.

The Company was initially established to develop miniaturised MS instruments based on micro-electromechanical systems (MEMS) technology originating at the highly regarded Optical and Semiconductor Devices Group at Imperial College London. Since being established in 2001, the Company has invested substantially in core intellectual property specific to its miniaturised MS, with over 60 patents in chip based, compact MS.

The Company has sold over 160 instruments to date and has signed over ten commercial partners, including in North America, Europe, China, SE Asia and Japan, with the majority of signings occurring in 2018 and 2019. For more information, please go to www.microsaic.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOATIMTTMTBMTFB
UK 100

Latest directors dealings